Загрузка...
Ultra-sensitive bioanalysis of the therapeutic peptide exenatide for accurate pharmacokinetic analyses at effective plasma concentrations utilizing UPLC-MS/MS
Exenatide is the first approved glucagon-like peptide 1 receptor agonist subcutaneously or intramuscularly injected for the treatment of type 2 diabetes mellitus. Typical therapeutic plasma concentrations are in the low pg/mL range, therefore requiring ultra-sensitive quantification. To enable the a...
Сохранить в:
| Опубликовано в: : | J Pharm Anal |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Xi'an Jiaotong University
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7322758/ https://ncbi.nlm.nih.gov/pubmed/32612869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpha.2020.02.008 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|